Skip to content
Home/Companies/Biotech/Follicum

Follicum

Biotech·Sweden·Exited 2014·Held 2yr
Entry
2012
Hold
2yr
Exit
2014

Who owns Follicum?

Follicum was owned by Sunstone Life Science Ventures through Sunstone Life Science Ventures III (2007 vintage) from 2012 to 2014, exited via IPO.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-18

Sunstone Life Science Ventures
Investor
Sunstone Life Science Ventures
Sunstone Life Science Ventures III · 2007 · VC

Key facts

HQSweden
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
MOIC
–
Exit Year
2014

More from Sunstone Life Science Ventures III

Other portfolio companies in the same fund.

MinervaX
MinervaX
Active
BiotechDenmark· 2014
Cantargia
Exited 2015
BiotechSweden· 2013
Opsona Therapeutics
Exited 2019
BiotechIreland· 2013
Galecto
Exited 2020
BiotechDenmark· 2012
Orphazyme
Orphazyme
Exited 2017
BiotechDenmark· 2011
Vaximm
Exited 2022
BiotechGermany· 2011
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Follicum

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Follicum?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Follicum.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue